Atrial Fibrillation and Chronic Heart Failure: Common Pathogenetic Pathways, Approaches to Treatment, Potential for Application of Artificial Intelligence
M. Utsumueva, N. Mironov, Sergey P. Golitsyn, Yulia A. Dolgusheva, Valeriy V. Beregovykh, Nikolay L. Schimanowsky
{"title":"Atrial Fibrillation and Chronic Heart Failure: Common Pathogenetic Pathways, Approaches to Treatment, Potential for Application of Artificial Intelligence","authors":"M. Utsumueva, N. Mironov, Sergey P. Golitsyn, Yulia A. Dolgusheva, Valeriy V. Beregovykh, Nikolay L. Schimanowsky","doi":"10.15690/vramn16009","DOIUrl":null,"url":null,"abstract":"Atrial fibrillation (AFib) and chronic heart failure (CHF) are frequently encountered cardiovascular conditions that share common causes and tend to coexist in some patients. Such coexistence represents a major issue due to augmentation of symptoms severity, rapid deterioration, and poor prognosis. Management of patients with AFib and CHF is challenging due to limitations in pharmacotherapy and decreased efficacy of cardiac interventions. In this review we focus on crucial pathogenic components of AFib and CHF coexistence, key treatment approaches and discuss potential for implementation of artificial intelligence.","PeriodicalId":178392,"journal":{"name":"Annals of the Russian academy of medical sciences","volume":"17 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the Russian academy of medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15690/vramn16009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Atrial fibrillation (AFib) and chronic heart failure (CHF) are frequently encountered cardiovascular conditions that share common causes and tend to coexist in some patients. Such coexistence represents a major issue due to augmentation of symptoms severity, rapid deterioration, and poor prognosis. Management of patients with AFib and CHF is challenging due to limitations in pharmacotherapy and decreased efficacy of cardiac interventions. In this review we focus on crucial pathogenic components of AFib and CHF coexistence, key treatment approaches and discuss potential for implementation of artificial intelligence.